Table 2.

Overall outcomes

Criteria	Control group (n = 15) Number of patients (%)	Test group (n = 15) Number of patients (%)
Qualified after training	N/A	15 (100)
Received adequate treatment	15 (100)	15 (100)
GH level maintained	15 (100)	14 (93)*
IGF-1 level maintained	14 (93)†	15 (100)
Overall treatment success	N/A	14 (93)

N/A, not applicable.

^*One patient (60-mg dose) had a GH level of 5·0 µg/l at Screening, 2·0 µg/l at Baseline, 3·3 µg/l at Interim assessment and 6·7 µg/l at Study Completion.

^†One patient (60-mg dose) had an IGF-1 level of 185 µg/l at Screening, 181 µg/l at Baseline, 194 µg/l at Interim assessment and 241 µg/l at Completion.